Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2013


Medical Affairs Seminar - Launching a High-Value Medical & Scientific Affairs Team

22 Jan 2013 - 23 Jan 2013 - Boston, MA, USA



Bookmark and Share


Medical Affairs Seminar - Launching A High-Value Medical & Scientific Affairs Team

During the past decade, Medical Affairs has become a critical function within all pharmaceutical and biotechnology companies. A high-performance Medical Affairs team will not only support but drive the safe, effective and appropriate use of medications throughout a product lifecycle. A Medical Affairs Department is now a necessity rather than a luxury. 

Launching a High Value Medical Affairs Team is an interactive learning opportunity for professionals who are setting up, expanding or restructuring Medical Affairs Departments and Groups. This program will help participants identify the needs of their organization, the appropriate structure and organizational alignment and identify critical functions, and will clarify many other operational aspects that are key to building a sustainable and respected department.

This conference will offer an opportunity to learn from others who have built Medical Affairs teams from the ground up, including the good, the bad and the ugly. Finally, and most important, the seminar is an excellent opportunity to pause from everyday duties, in order to reflect on your medical affairs strategies and tactics, and exchange experiences through networking and discussion with your peers.



Further information
Scientific News
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
UTSW Researchers Identifies How Drugs Alter Pancreatic Cancer Cells
The findings were published in Cell Reports.
Researchers Identify Process that Causes Chronic Neonatal Lung Disease
Study determines how the NLRP3 inflammasome activates the protein Interleukin 1 beta.
Dengue Vaccine Enters Phase 3 Trial
Investigational vaccine to prevent ‘breakbone fever’ developed at NIH.
Trying to Conceive Soon After a Pregnancy Loss May Increase Chances of Live Birth
NIH study finds no reason for delaying pregnancy attempts after a loss without complications.
BRCA1 Deficiency Increases the Sensitivity of Ovarian Cancer Cells to Auranofin
An anti-rheumatic drug could improve the prognosis for ovarian cancer patients exhibiting a deficiency of the DNA repair protein BRCA1, a study suggests.
Shingles Vaccine Helps Protect Older Patients with End-stage Renal Disease
Kaiser Permanente study advances knowledge about safety and effectiveness of vaccine commonly given to older adults.
AMRI Acquires Whitehouse Laboratories
Strategically extends AMRI's analytical offerings in rapidly expanding area of outsourcing services.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!